Sign In
Buy KDMN
$9.50
+0 (+0%)
At Close: Aug 17, 2022
7 Penny Stocks To Buy According To Analysts With Targets Up To 316%
01:26pm, Thursday, 22'nd Jul 2021
Analysts say these are penny stocks to buy. Do you agree?
Kadmon's REZUROCK Scores Quick FDA Win For Chronic Graft-Versus-Host Disease
06:26am, Monday, 19'th Jul 2021
Friday afternoon, the FDA approved Kadmon Holdings Inc's (NASDAQ: KDMN) REZUROCK to treat chronic graft-versus-host disease (cGVHD), a serious complication of transplant procedures. Formerly known
Kadmon's graft-versus-host treatment gets FDA approval
02:34pm, Friday, 16'th Jul 2021
Kadmon Holdings Inc. said Friday that Rezurock, its treatment of chronic graft-versus-host disease (cGVHD) in adjusts and pediatric patients older than 12 was approved by the Food and Drug Administrat
- REZUROCK is approved for the treatment of adult and pediatric patients 12 years and older with cGVHD after failure of at least two prior lines of systemic therapy - - Kadmon to Host Conference Call
NEW YORK, June 2, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between October 1, 2020 and
Los Angeles, California--(Newsfile Corp. - June 2, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Kadmon Holdings, Inc.
New York, New York--(Newsfile Corp. - June 2, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Kad
Los Angeles, California--(Newsfile Corp. - June 1, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Kadmon Holdings, Inc.
New York, New York--(Newsfile Corp. - June 1, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between Octob
NEW YORK, June 1, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Kadmon Holdings, Inc. ("Kadmon" or the "Company") (NASDAQ: KDMN) and certain of its o
New York, New York--(Newsfile Corp. - May 31, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of K
New York, New York--(Newsfile Corp. - May 31, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Kadmon Holdings, Inc. ("Kadmon" or the "C
Los Angeles, California--(Newsfile Corp. - May 31, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Kadmon Holdings, Inc.
New York, New York--(Newsfile Corp. - May 29, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Kadmon Holdings, Inc. ("Kadmon" or the "Company") (NASDAQ: KDMN) and ce
New York, New York--(Newsfile Corp. - May 29, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kadmon Holdings, Inc. (NASDAQ: KDMN) between Octob
